Dillon M. Voss - Concepedia

Author

Dillon M. Voss

Also Known As

Dillon M Voss, Dillon M. Voss, Dillon Voss

Publications

303

Citations

H-Index

Concepts

All Affiliations

Dillon M. Voss is an author at Case Western Reserve University specializing in cell biology, medicine, and gene expression.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	96
2	Cell Biology	3	3	96
3	Health Sciences	1	1	31
4	Natural Sciences	1	1	12
5	Cellular Physiology	1	1	53

Dillon M. Voss

Publications

281

Citations

H-Index

Page 1

	Year	Citations
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth Wai Kit, Dillon M. Voss, Juergen Scharner, Cancer Research	2021	108
Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression Dillon M. Voss, Raffaella Spina, David L. Carter, Scientific Reports Hypoxic ResponseChemoprevention StrategyTumor ProgressionCancer BiologyGlioma	2017	53
Exon-skipping antisense oligonucleotides for cystic fibrosis therapy Young Jin Kim, Nicole Sivetz, Jessica Layne, Proceedings of the National Academy of Sciences	2022	37
The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness Dillon M. Voss, Anthony Sloan, Raffaella Spina, Cancer Research Hypoxia-induced StemnessMbnl1 ActivityCancer BiologyGliomaSplicing Variant	2020	31
Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells Raffaella Spina, Dillon M. Voss, Laura Asnaghi, Oncotarget	2015	26
Screening Splice-Switching Antisense Oligonucleotides in Pancreas-Cancer Organoids Ledong Wan, Alexander J. Kral, Dillon M. Voss, Nucleic Acid Therapeutics	2024	14
Exon-Skipping Antisense Oligonucleotides for Cystic Fibrosis Therapy Young Jin Kim, Nicole Sivetz, Jessica Layne, Read-through TherapiesMolecular PhysiologySignal TransductionNatural SciencesOther Cftr-modulation Therapies	2021	12

Page 1